1. Home
  2. AWRE vs INKT Comparison

AWRE vs INKT Comparison

Compare AWRE & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AWRE
  • INKT
  • Stock Information
  • Founded
  • AWRE 1986
  • INKT 2017
  • Country
  • AWRE United States
  • INKT United States
  • Employees
  • AWRE N/A
  • INKT N/A
  • Industry
  • AWRE Computer Software: Prepackaged Software
  • INKT Medicinal Chemicals and Botanical Products
  • Sector
  • AWRE Technology
  • INKT Health Care
  • Exchange
  • AWRE Nasdaq
  • INKT Nasdaq
  • Market Cap
  • AWRE 34.6M
  • INKT 28.8M
  • IPO Year
  • AWRE 1996
  • INKT 2021
  • Fundamental
  • Price
  • AWRE $2.21
  • INKT $62.86
  • Analyst Decision
  • AWRE
  • INKT Strong Buy
  • Analyst Count
  • AWRE 0
  • INKT 2
  • Target Price
  • AWRE N/A
  • INKT $37.50
  • AVG Volume (30 Days)
  • AWRE 62.6K
  • INKT 2.4M
  • Earning Date
  • AWRE 08-07-2025
  • INKT 08-12-2025
  • Dividend Yield
  • AWRE N/A
  • INKT N/A
  • EPS Growth
  • AWRE N/A
  • INKT N/A
  • EPS
  • AWRE N/A
  • INKT N/A
  • Revenue
  • AWRE $16,576,000.00
  • INKT N/A
  • Revenue This Year
  • AWRE N/A
  • INKT N/A
  • Revenue Next Year
  • AWRE N/A
  • INKT N/A
  • P/E Ratio
  • AWRE N/A
  • INKT N/A
  • Revenue Growth
  • AWRE N/A
  • INKT N/A
  • 52 Week Low
  • AWRE $1.35
  • INKT $4.56
  • 52 Week High
  • AWRE $2.97
  • INKT $76.00
  • Technical
  • Relative Strength Index (RSI)
  • AWRE 74.91
  • INKT 57.39
  • Support Level
  • AWRE $1.78
  • INKT $6.80
  • Resistance Level
  • AWRE $1.93
  • INKT $7.88
  • Average True Range (ATR)
  • AWRE 0.12
  • INKT 0.40
  • MACD
  • AWRE 0.03
  • INKT 0.02
  • Stochastic Oscillator
  • AWRE 80.00
  • INKT 58.86

About AWRE Aware Inc.

Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.

Share on Social Networks: